Results 151 to 160 of about 24,922 (273)

The Management of Parkinson's Disease Before, during and after Pregnancy—an MDS Scientific Issues Committee Review

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 1, Page 44-59, January 2026.
Abstract Background Pregnancy after a Parkinson's diagnosis presents complex challenges. Due to the paucity of literature, there is no evidence‐based guidelines and protocols for preconception care, management of pregnancy, childbirth and the postpartum period in women with early‐onset Parkinson's disease (PD).
Alexander C. Lehn   +18 more
wiley   +1 more source

The Influence of Genetics in the Early Development of Axial Postural Abnormalities in Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 1, Page 230-235, January 2026.
ABSTRACT Background Postural abnormalities (PA) can complicate Parkinson's disease (PD). While age and motor severity are established predictors, the genetic role remains underexplored. Objective To evaluate the influence of major genetic variants on PA development in PD over 4 years.
Ilaria A. Di Vico   +6 more
wiley   +1 more source

The Potential Therapeutic Effects of Botulinum Neurotoxins on Neoplastic Cells: A Comprehensive Review of In Vitro and In Vivo Studies

open access: yesToxins
A systematic review of the literature found fifteen articles on the effect of a botulinum toxin on neoplastic cell lines and eight articles on in vivo neoplasms.
Delaram Safarpour   +2 more
doaj   +1 more source

Botulinum Neurotoxins [PDF]

open access: yes, 2012
Webb, Robert P.   +2 more
openaire   +2 more sources

Pro‐Inflammatory Signaling in Dermal Fibroblasts: A Possible Role of Different Botulinum Toxin Formulations on IL‐6 Expression

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background Botulinum toxin type A (BoNT‐A) formulations are extensively employed in aesthetic and therapeutic dermatology. However, their immunomodulatory and pro‐inflammatory properties remain incompletely characterized, particularly concerning dermal fibroblasts. Aims This study aimed to evaluate and compare the effects of three commercially
Sabrina Sommatis   +10 more
wiley   +1 more source

Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes

open access: green, 2007
Kristin M. Marshall   +3 more
openalex   +1 more source

Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta‐Analysis of Clinical Studies

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background Botulinum toxin type A (BoNT‐A) is widely recognized as the leading nonsurgical cosmetic treatment worldwide for diminishing dynamic wrinkles in the glabellar, forehead, and periorbital areas. While BoNT‐A is widely acknowledged for its effectiveness and popularity, there are notable inconsistencies in results, methodologies, and ...
Alaa Safia   +4 more
wiley   +1 more source

Hsp90 is involved in the entry of clostridial neurotoxins into the cytosol of nerve terminals [PDF]

open access: yes, 2016
AZARNIA TEHRAN, Domenico   +7 more
core   +1 more source

Finely Tuned Gamma Oscillations in the Globus Pallidus Internus in Parkinson's Disease

open access: yes
Movement Disorders Clinical Practice, Volume 13, Issue 1, Page 294-296, January 2026.
Hikaru Kamo   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy